The pharmaceuticals in dosage market size value per capita in Canada was noted to be USD 907.35 in 2023. Forecasted data indicates a gradual decline in value per capita from USD 905.68 in 2024 to USD 894.89 in 2028. The year-on-year variations between 2024 and 2028 are minor, with a consistent downturn visible each year. Specifically, the variations from 2024 to 2025, 2025 to 2026, 2026 to 2027, and 2027 to 2028 are -0.37%, -0.32%, -0.27%, and -0.23%, respectively. The cumulative average growth rate (CAGR) from 2024 to 2028 stands at approximately -0.30%, indicating a slight annual decrease in the market.
Future trends to watch for include potential market stabilization driven by advancements in generic drugs, regulatory changes, and innovation in drug delivery technologies. Increased healthcare awareness and an aging population might also counteract the declining trend, leading to new growth opportunities in the sector.
